When to Conduct Molecular Testing in NSCLC

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on when to conduct biomarker testing in NSCLC.

Related Content:

Biomarker Testing In Non–Small Cell Lung CancerLung CancerPrecision Medicine in Oncology®

Osimertinib Approaches EU Approval in Locally Advanced EGFR+ NSCLC After Chemoradiation

Dr Pobel on the Prognostic Value of Phenotypic and Genomic Characterization in De Novo mCSPC

Zorifertinib Receives NMPA Approval for EGFR+ NSCLC With CNS Metastases